Connect Biopharma Holdings Limited American Depositary Shares

Go to Connect Biopharma Holdings Limited American Depositary Shares Website

$2.19

0.15 (7.35%)
Live
Previous Close

$2.2

Day Range

$1.9372 - $2.2

Previous Day Range

$1.87 - $2.11

Market Cap

$113.3 million USD

Day Vol.

80072

Previous Day Vol.

129418

Currency

USD

Primary Exchange

Nasdaq

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology ...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Connect Biopharma will present at the BTIG Virtual Biotechnology Conference on July 29th, 2025, discussing their clinical-stage development of rademikibart, an antibody targeting IL-4Rα for treating asthma and COPD.

Related tickers: CNTB.

Read Full Article

Connect Biopharma presented positive data on its investigational drug rademikibart, which showed significant improvements in lung function and reduced asthma exacerbations in patients with eosinophilic-driven type 2 asthma.

Related tickers: CNTB.

Read Full Article
Trending Tickers

Please sign in to view